Join the club for FREE to access the whole archive and other member benefits.


Global medicines company for developing and producing drugs.

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.

Visit website:

Novartis Creations


Prescription gene therapy product for treatment of inherited retinal disease

People at Novartis

Company Representative

Chief Executive Officer of Novartis.

Company Representative

Head of informatics systems at Novartis Institutes for Biomedical Research in Cambridge.

Novartis News

$95M raised by Taysha for clinical trials of four new gene therapies

FierceBiotech - 05-Aug-2020

Company has gathered support from investors to quickly lead therapies to clinic then market


Adicet merges with resTorbio for CAR T-cell therapy pipeline funding

FierceBiotech - 30-Apr-2020

The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year


First gene therapy for a rare eye disease, now NHS-approved

BBC - 17-Feb-2020

This life-changing new gene therapy will halt sight loss and improve vision


Competitors in big pharma accused of conspiring to inflate generic drug prices

Independent - 12-May-2019

Inflated prices of more than 100 generic drugs by as much as 1000 per cent